This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ambit Biosciences Corporation. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: The Innovations of Robert E Corringham
Introduction
Robert E Corringham is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicine, particularly in the treatment of proliferative diseases. With a total of 2 patents to his name, his work has the potential to impact patient care positively.
Latest Patents
Corringham's latest patents focus on methods of treating proliferative diseases. One of his patents details the administration of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or a pharmaceutically acceptable salt or solvate thereof, to human patients. This patent includes specific dosing schedules and regimens tailored for particular patient populations. Additionally, he has developed methods for treating FLT-3 mediated diseases in humans, showcasing his commitment to advancing medical treatments.
Career Highlights
Corringham is associated with Ambit Biosciences Corporation, where he continues to innovate in the pharmaceutical field. His work is characterized by a focus on developing effective therapies for challenging medical conditions.
Collaborations
Some of his notable coworkers include Patrick B O'Donnell and Joyce K James, who contribute to the collaborative environment at Ambit Biosciences Corporation.
Conclusion
Robert E Corringham's contributions to the field of medicine through his patents and work at Ambit Biosciences Corporation highlight his dedication to improving patient outcomes. His innovative approaches to treating proliferative diseases are paving the way for future advancements in medical therapies.